Rezubio Pharmaceuticals Co., Ltd.
PrivateLast Round
Series A
Dec 18, 2025
Total Funding Raised
$20M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Rezubio Pharmaceuticals Co., Ltd. is a biotechnology company that develops tissue-selective therapeutics for metabolic, inflammatory, and degenerative diseases using its proprietary Membrane-Anchored Drug Design (MADD) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rezubio Pharmaceuticals Co., Ltd. Comparables
Compare Rezubio Pharmaceuticals Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Glyscend Therapeutics | 77% | |
| Kallyope | 77% | |
| SCOHIA PHARMA, Inc. | 73% |
Rezubio Pharmaceuticals Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 18, 2025 | ||||
| Pre Seed | Feb 16, 2023 | ||||
| Angel | Sep 1, 2019 |
Rezubio Pharmaceuticals Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GF Qianhe Investment | Pre Seed |
| Lapam Capital | Series A |
| Huajin Capital | Pre Seed |
| Hengqin Financial Investment Group | Angel |
| Hanne Capital | Angel |
| Sunshine Riverhead Capital Investment Management Co., Ltd. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 18, 2025
$20M round led by Lapam Capital
- Feb 16, 2023
Raised Pre Seed round with GF Qianhe Investment and Huajin Capital.
Rezubio Pharmaceuticals Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rezubio Pharmaceuticals Co., Ltd.'s valuation, stock price, and market status.
Is Rezubio Pharmaceuticals Co., Ltd. a public or private company?
Rezubio Pharmaceuticals Co., Ltd. is a private company.
What is the current stock price of Rezubio Pharmaceuticals Co., Ltd.?
Rezubio Pharmaceuticals Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Rezubio Pharmaceuticals Co., Ltd. worth (valuation)?
Valuation information for Rezubio Pharmaceuticals Co., Ltd. is not publicly available.
Can I buy Rezubio Pharmaceuticals Co., Ltd. stock?
Rezubio Pharmaceuticals Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rezubio Pharmaceuticals Co., Ltd.'s last funding round?
Rezubio Pharmaceuticals Co., Ltd.'s most recent funding round was Series A on December 18, 2025.
Who are the main investors in Rezubio Pharmaceuticals Co., Ltd.?
Key investors in Rezubio Pharmaceuticals Co., Ltd. include Lapam Capital.
Will Rezubio Pharmaceuticals Co., Ltd. IPO soon?
No public IPO plans have been announced for Rezubio Pharmaceuticals Co., Ltd..
How can I track Rezubio Pharmaceuticals Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rezubio Pharmaceuticals Co., Ltd.'s secondary market activity and sign up for updates.